Walter Greenblatt & Associates helps biotechnology and medical device companies succeed through strategic planning, capital raising and mergers and acquisitions.

We serve biotechnology and medical device companies of virtually all sizes from very early stage startups to established public companies.

Walter Greenblatt & Associates serves as the translator between scientists and potential investors:

We help scientists develop a strategic plan that explains the scientific and economic promise of their technology to non-scientists
We assist scientists in understanding the value of their idea and guide them through the appropriate capital raising process to help it to reach the next stage of development.
We enable established companies to maximize shareholder value through strategic alliances, mergers and acquisitions and divestitures.

Walter Greenblatt & Associates, LLC, (Member NASD, Member SIPC) offers securities in states in which the firm and its Principals are registered or where it is exempt from registration.

Walter Greenblatt & Associates, LLC

430 Nassau Street

Princeton, New Jersey 08540

Phone: (609) 497-1282

Fax: (609) 497-0793

Member NASD

Member SIPC

Our Privacy Policy Business Continuity Plan Disclosure Statement

What's New with Our Clients:

MedAvante closes $20 Million Financing Led by Goldman Sachs and Trevi Health Ventures

Lerner Medical closes $3.3 Million Angel Financing

MedAvante closes $6.7 Million Financing